What is the current stock price of HilleVax, Inc. (HLVX)?

As of the latest market data, HilleVax, Inc. (HLVX) is trading at $2.09. The stock has seen a loss of -0.48% today.

Does HilleVax, Inc. (HLVX) pay a dividend?

Based on current data, HilleVax, Inc. does not have a confirmed active dividend policy.

What is the market cap of HilleVax, Inc.?

The current market capitalization of HilleVax, Inc. (HLVX) is approximately unavailable.

HLVX

HilleVax, Inc.·Healthcare

2.09

0.476%(−0.01)

Market Closed

2.11

0.957%(+0.02)

After Hours

Last Updated: — ET

52W L: $1.3452W H: $2.17

Company Profile

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2022-04-29

Beta

0.77

Websitewww.hillevax.com↗